Stress Phenotypes and Preterm Birth: Immune and Energetic Cellular Dysregulation and the Preventive Effect of Social Support

压力表型和早产:免疫和能量细胞失调以及社会支持的预防作用

基本信息

项目摘要

PROJECT ABSTRACT At odds with common assumptions — and hope, pregnancy ends in preterm birth (PTB) for approximately 1 in 10 women. Yearly PTB affects 15 million infants worldwide and 386,580 in the United States. PTB is the leading cause of global, and U.S., neonatal mortality and morbidity and is associated with future risk for poor physical (higher blood pressure, chronic kidney disease, wheeze/asthma) and mental (ADHD, IQ decrements) health. Maternal health is not spared: women who deliver preterm are at an increased risk for depression, hypertension, cardiovascular and renal disease later in life. In the U.S., the racial and ethnic disparities in PTB rates are dramatic and independent of socio-economic status (SES): overall, 14.12% for Non-Hispanic Black compared to 9.09% for Non-Hispanic White women. Psychosocial stress and childhood trauma each are associated with risk for PTB. PTB has an intergenerational impact: mothers born preterm are more likely to give birth pretern, especially amongst Black women. Biomarkers to predict PTB have proven unsuccessful, and do not account for this emerging recognition of intergenerational transmission of PTB risk specifically via maternal heritage. Mitochondria, which contain their own genome, the mitochondria DNA, are inherited from the mother and represent a potential intersection point between psychosocial experiences and their biological embedding, including via immune dysregulation, in underlying disease outcomes. We aim to apply a mitochondria psychobiology approach to delineate by which mechanisms life stress — including discrimination and childhood trauma — results in disproportionate risk of PTB in minority women, and evaluate mitochondria as potential biomarkers of this birth outcome. In a sample of post-attrition n=175 pregnant women we will test the following three aims: Aim 1: To determine whether a data driven approach to multiple, 1st trimester psychosocial (self- report stress discrimination, 24-hour ambulatory mood, social support), lifecourse (hair cortisol, childhood trauma), and biological variables (acute laboratory physiological stress reactivity) generate unique stress profiles that partially explain the racial/ethnic differences in gestational age at birth. Aim 2: To identify molecular indices of mitochondrial and immune functioning in the mother (3x blood draw), placenta, and fetal cord blood that mediate the association between 1st trimester maternal stress phenotypes and risk for earlier gestational age at birth. Aim 3: To evaluate if reduction in stress levels and/or improvement in social support over the course of pregnancy is associated with molecular indices of mitochondrial and immune functioning and (exploratory) reduced risk of earlier birth relative to national and hospital norms. This new conceptual framing of this adverse health outcome (1) incorporates evidence of the psychosocial factors contributing to risk, (2) aims to account for the racial/ethnic disparities, and (3) harnesses cutting-edge mitochondria knowledge and tools to better characterize PTB’s pathophysiology and identify novel targets for its intervention and prevention.
项目摘要 与共同的假设不一致 - 希望,怀孕在早产(PTB)中结束了约1英寸 10名女性。在美国,年度PTB每年影响全球1500万婴儿,386,580名婴儿。 PTB是领导者 全球和美国的原因,新生儿死亡率和发病率,与身体不良的未来风险有关 (较高的血压,慢性肾脏疾病,喘息/哮喘)和心理(ADHD,智商降低)健康。 孕产妇的健康并不幸运:交付早产的妇女患抑郁症,高血压,高血压的风险增加 心血管和肾脏疾病后期。在美国,PTB利率的种族和种族差异是 戏剧性和独立于社会经济地位(SES):总体而言,非西班牙裔黑色比较14.12% 非西班牙裔白人妇女为9.09%。社会心理压力和儿童创伤都与 PTB的风险。 PTB有代际影响:出生的母亲更有可能生育预期, 特别是在黑人妇女中。预测PTB的生物标志物已证明没有成功,并且不考虑 对PTB风险的代际传播的新出现的认识,专门通过材料遗产。 线粒体包含自己的基因组,线粒体DNA,是从母亲那里继承的, 代表社会心理经历与其生物嵌入之间的潜在相交点, 包括免疫失调,在潜在的疾病结局中。我们的目标是应用线粒体 精神生物学方法描述了生命压力的机制 - 包括歧视和童年 创伤 - 少数妇女的PTB风险不成比例,并评估线粒体为潜在 这种出生结果的生物标志物。在引起后n = 175名孕妇的样本中,我们将测试以下 三个目的:目标1:确定数据驱动方法是否采用多个,第一个三个月的心理社会心理(自我) 举报压力歧视,24小时的门诊情绪,社会支持),生命力(皮质醇,童年 创伤)和生物学变量(急性实验室生理压力反应性)产生独特的应力曲线 这部分解释了出生时胎龄的种族/种族差异。目标2:确定分子指数 母亲的线粒体和免疫功能(3x抽血),胎盘和胎儿血液 调解第一例三个月材料应力表型与早期妊娠年龄的风险之间的关联 生日。目标3:评估在整个过程中的压力水平降低和/或社会支持的改善 妊娠与线粒体和免疫功能的分子指数以及(探索性)有关 相对于国家和医院规范,较早出生的风险降低。这种逆境的新概念框架 健康结果(1)结合了导致风险的社会心理因素的证据,(2)旨在说明 种族/种族差异,以及(3)利用尖端的线粒体知识和工具以更好 表征PTB的病理生理学并确定其干预和预防的新目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CYNTHIA GYAMFI-BANNERMAN其他文献

CYNTHIA GYAMFI-BANNERMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CYNTHIA GYAMFI-BANNERMAN', 18)}}的其他基金

PREBIC Global 2020 Annual Meeting in Ghana
加纳 PREBIC 2020 年全球年会
  • 批准号:
    10481157
  • 财政年份:
    2021
  • 资助金额:
    $ 67.26万
  • 项目类别:
Stress Phenotypes and Preterm Birth: Immune and Energetic Cellular Dysregulation and the Preventive Effect of Social Support
压力表型和早产:免疫和能量细胞失调以及社会支持的预防作用
  • 批准号:
    10618991
  • 财政年份:
    2021
  • 资助金额:
    $ 67.26万
  • 项目类别:
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Clinical Coordinating Center (ALPS-FS: CCC)
产前皮质类固醇随机试验后出生队列的肺部并发症:ALPS 随访研究 - 临床协调中心 (ALPS-FS: CCC)
  • 批准号:
    9977250
  • 财政年份:
    2010
  • 资助金额:
    $ 67.26万
  • 项目类别:
Randomized Trial of Antenatal Late Preterm Steroids (ALPS) - Clinical Coordinatin
产前晚期早产类固醇 (ALPS) 的随机试验 - 临床协调
  • 批准号:
    8120579
  • 财政年份:
    2010
  • 资助金额:
    $ 67.26万
  • 项目类别:
Randomized Trial of Antenatal Late Preterm Steroids (ALPS) - Clinical Coordinatin
产前晚期早产类固醇 (ALPS) 的随机试验 - 临床协调
  • 批准号:
    7770407
  • 财政年份:
    2010
  • 资助金额:
    $ 67.26万
  • 项目类别:
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Clinical Coordinating Center (ALPS-FS: CCC)
产前皮质类固醇随机试验后出生队列的肺部并发症:ALPS 随访研究 - 临床协调中心 (ALPS-FS: CCC)
  • 批准号:
    9176913
  • 财政年份:
    2010
  • 资助金额:
    $ 67.26万
  • 项目类别:
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Clinical Coordinating Center (ALPS-FS: CCC)
产前皮质类固醇随机试验后出生队列的肺部并发症:ALPS 随访研究 - 临床协调中心 (ALPS-FS: CCC)
  • 批准号:
    9345579
  • 财政年份:
    2010
  • 资助金额:
    $ 67.26万
  • 项目类别:
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Clinical Coordinating Center (ALPS-FS: CCC)
产前皮质类固醇随机试验后出生队列的肺部并发症:ALPS 随访研究 - 临床协调中心 (ALPS-FS: CCC)
  • 批准号:
    10511115
  • 财政年份:
    2010
  • 资助金额:
    $ 67.26万
  • 项目类别:
Randomized Trial of Antenatal Late Preterm Steroids (ALPS) - Clinical Coordinatin
产前晚期早产类固醇 (ALPS) 的随机试验 - 临床协调
  • 批准号:
    8306803
  • 财政年份:
    2010
  • 资助金额:
    $ 67.26万
  • 项目类别:
Maternal-Fetal Medicine Units (MFMU) Network
母胎医学单位 (MFMU) 网络
  • 批准号:
    9229560
  • 财政年份:
    2001
  • 资助金额:
    $ 67.26万
  • 项目类别:

相似国自然基金

LPGAT1介导的磷脂重塑影响Treg细胞分化及功能参与哮喘发病机制研究
  • 批准号:
    82370032
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
咳喘停穴位贴敷通过PI3K/AKT/c-Rel调控ILC2s-ICOSL影响Th2免疫应答参与过敏性哮喘的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
哮喘易感转录因子Bach2调控Treg细胞影响气道高反应性的作用机制研究
  • 批准号:
    82270027
  • 批准年份:
    2022
  • 资助金额:
    53.00 万元
  • 项目类别:
    面上项目
哮喘患者痛觉异常对电针疗效影响的动态脑效应机制研究
  • 批准号:
    82205267
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
固本防哮饮调控RTN4B介导鞘脂代谢稳态影响哮喘气道重塑的机制研究
  • 批准号:
    82205186
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

PIWIL4 and piRNAs in RSV Infection
RSV 感染中的 PIWIL4 和 piRNA
  • 批准号:
    10667951
  • 财政年份:
    2023
  • 资助金额:
    $ 67.26万
  • 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
  • 批准号:
    10813753
  • 财政年份:
    2023
  • 资助金额:
    $ 67.26万
  • 项目类别:
Heterogeneity and cellular hierarchy of lung cDC2
肺 cDC2 的异质性和细胞层次
  • 批准号:
    10665348
  • 财政年份:
    2023
  • 资助金额:
    $ 67.26万
  • 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
  • 批准号:
    10649012
  • 财政年份:
    2023
  • 资助金额:
    $ 67.26万
  • 项目类别:
Extraction of Vital Signs using a Telehealth Application for Asthma - EViTA-AThe purpose of this grant is to evaluate mobile devices to extract vitals signs to monitor patients with Asthma
使用哮喘远程医疗应用程序提取生命体征 - EViTA-A 这项拨款的目的是评估移动设备提取生命体征以监测哮喘患者
  • 批准号:
    10699530
  • 财政年份:
    2023
  • 资助金额:
    $ 67.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了